Primary sclerosing cholangitis is a liver condition whose exact cause is not known Four genes associated with an increased risk of the condition, making the total number of genes associated with ...

Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Primary Sclerosing Cholangitis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Primary Sclerosing ...

SCLEROSING cholangitis is a rare clinical entity. We found only 20 unequivocal cases reported in the past forty years. 1–3 A number of other reported cases do not meet the criteria for this entity.

DelveInsight's, “Primary Sclerosing Cholangitis Pipeline Insight, 2025,” report provides comprehensive insights about 14+ companies and 14+ pipeline drugs in Primary Sclerosing Cholangitis pipeline ...

Background Following a motorcycle accident, a 30-year-old male with multiple traumas—including liver rupture, traumatic fractures, cerebral hemorrhage, hepatic hematoma and respiratory failure—was ...

PARIS — Statins can significantly reduce the risk for complications and death from primary sclerosing cholangitis, results from a Swedish registry study show. Primary sclerosing cholangitis is ...

Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and extrahepatic bile ducts through ...

IgG4-associated cholangitis is a steroid-responsive hepatobiliary inflammatory condition associated with autoimmune pancreatitis that clinically and radiologically mimics primary sclerosing ...

Autoimmune features negatively influenced pediatric sclerosing cholangitis, but concomitant inflammatory bowel disease did not, according to a recently published study. “Pediatric sclerosing ...